Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery
- PMID: 28990150
- PMCID: PMC5880852
- DOI: 10.1007/s11695-017-2953-6
Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery
Abstract
Purpose: The impact of weight loss on obesity-related colorectal cancer (CRC) risk is not well defined. Previous studies have suggested that Roux-en-Y gastric bypass (RYGB) surgery may have an unexpected adverse impact on CRC risk. This study aimed to investigate the impact of RYGB on biomarkers of CRC risk.
Materials and methods: Rectal mucosal biopsies and blood were obtained from patients undergoing RYGB (n = 22) and non-obese control participants (n = 20) at baseline and at a median of 6.5 months after surgery. Markers of systemic inflammation and glucose homeostasis were measured. Expression of pro-inflammatory genes and proto-oncogenes in the rectal mucosa was quantified using qPCR. Crypt cell proliferation state of the rectal mucosa was assessed by counting mitotic figures in whole micro-dissected crypts.
Results: At 6.5 months post-surgery, participants had lost 29 kg body mass and showed improvements in markers of glucose homeostasis and in systemic inflammation. Expression of pro-inflammatory genes in the rectal mucosa did not increase and COX-1 expression fell significantly (P = 0.019). The mean number of mitoses per crypt decreased from 6.5 to 4.3 (P = 0.028) after RYGB.
Conclusion: RYGB in obese adults led to lower rectal crypt cell proliferation, reduced systemic and mucosal markers of inflammation and improvements in glucose regulation. These consistent findings of reduced markers of tumourigenic potential suggest that surgically induced weight loss may lower CRC risk.
Keywords: Bariatric surgery; Colorectal cancer; Gastric bypass; Obesity; Proliferation.
Conflict of interest statement
Conflict of Interest
The authors declare that they have no conflicts of interest.
Ethical Statement
The study was approved by the Newcastle & North Tyneside National Research Ethics Service Committee (13/NE/0204).
Consent Statement
Informed written consent was obtained from all participants.
Figures


Similar articles
-
Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB.Gut. 2011 Jul;60(7):893-901. doi: 10.1136/gut.2010.230755. Epub 2011 Feb 8. Gut. 2011. PMID: 21303912
-
Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass.Obesity (Silver Spring). 2014 Jan;22(1):202-10. doi: 10.1002/oby.20493. Obesity (Silver Spring). 2014. PMID: 23625552
-
Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass.Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1401-10. doi: 10.1158/1055-9965.EPI-07-2874. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559555
-
The impact of bariatric surgery on colorectal cancer risk.Surg Obes Relat Dis. 2023 Feb;19(2):144-157. doi: 10.1016/j.soard.2022.10.016. Epub 2022 Oct 28. Surg Obes Relat Dis. 2023. PMID: 36446717 Review.
-
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.Dan Med J. 2015 Apr;62(4):B5057. Dan Med J. 2015. PMID: 25872541 Review.
Cited by
-
The Feasibility of Examining the Effects of Gastric Bypass Surgery on Intestinal Metabolism: Prospective, Longitudinal Mechanistic Clinical Trial.JMIR Res Protoc. 2019 Jan 24;8(1):e12459. doi: 10.2196/12459. JMIR Res Protoc. 2019. PMID: 30679147 Free PMC article.
-
Effects of obesity, and of weight loss following bariatric surgery, on methylation of DNA from the rectal mucosa and in cell-free DNA from blood.Int J Obes (Lond). 2023 Dec;47(12):1278-1285. doi: 10.1038/s41366-023-01384-4. Epub 2023 Sep 15. Int J Obes (Lond). 2023. PMID: 37714902
-
Bariatric Surgery Is Associated with Lower Concentrations of Fecal Secondary Bile Acids and Their Metabolizing Microbial Enzymes: A Pilot Study.Obes Surg. 2024 Sep;34(9):3420-3433. doi: 10.1007/s11695-024-07420-0. Epub 2024 Jul 23. Obes Surg. 2024. PMID: 39042309 Free PMC article.
-
The Impact of Obesity and Metabolic Surgery on Chronic Inflammation.Obes Surg. 2018 Oct;28(10):3028-3040. doi: 10.1007/s11695-018-3320-y. Obes Surg. 2018. PMID: 29876839
-
Metabolic and bariatric surgery and obesity pharmacotherapy for cancer prevention: current status and future possibilities.J Natl Cancer Inst Monogr. 2023 May 4;2023(61):68-76. doi: 10.1093/jncimonographs/lgad003. J Natl Cancer Inst Monogr. 2023. PMID: 37139980 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials